Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Hizentra 4g/20ml


May be acceptable

May be acceptable
Use with caution
Hizentra 4g/20ml :
Type Medicine Authorised
Originator BioHuman (Human Ig 4g/20ml)
Agent Benta Trading Co
Distributor Benta Trading Co
Laboratory CSL Behring
Manufacturer Benta SAL
Manufacturing Type Packaging
Origin Lebanon
ATC J06BA02

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date : 01/07/2018

Hizentra 4g/20ml  MoH 9718 :
Form Solution for injection
Packaging Bottle
Package Size 20ml
Strength 4g/20ml
Public Price 34170481,01 L.L.
Stratum D
NSSF
Quarantine
Reg. Number 172818/1
Submission date 01/01/2018
Registration Year 2019




NB : Reregistration in 2019 with local manufacturer


Price Comparison

Country: Lebanon
Form: Solution for injection
Package Size: 20ml
Public Price: 34170481.01 LBP ( 34,170,481.01 LBP )
Pack size unit used: 20
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Pricing Date: 10/01/2024

Country: Denmark
Package Size: 1x20 ml
Public Price: 2266.45 DKK ( 5,577,665.46 LBP )
Pack size unit used: 20
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Pharmacy Price: 1680 DKK ( 4134429.6 LBP )
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Authorised

Country: UK
Package Size: 1x20ml
Public Price: 276 GBP ( 5,561,612.52 LBP )
Pack size unit used: 20
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: Germany
Package Size: 20x20ml
Public Price: 5898.98 EUR ( 108,423,547.35 LBP )
Pack size unit used: 400
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Pricing Date: 24/10/2020
Type: Medicine Authorised

Country: Cyprus
Package Size: 1x20ml
Public Price: 249.63 EUR ( 4,588,211.88 LBP )
Pack size unit used: 20
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Reference: Cyprus Minister of Health
Pricing Date: 24/03/2021
Type: Medicine Authorised

Country: Spain
Package Size: 20 x20 ml
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Common variable immunodeficiency :
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Cost/Day: 47838673,4 LBP ( 47,838,673.00 LBP )
Cost/Month: 956773468 LBP ( 956,773,468.00 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Cost/Day: 47838673,4 LBP ( 47,838,673.00 LBP )
Cost/Month: 956773468 LBP ( 956,773,468.00 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Cost/Day: 47838673,4 LBP ( 47,838,673.00 LBP )
Cost/Month: 956773468 LBP ( 956,773,468.00 LBP )
IgG subclass deficiencies :
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Cost/Day: 47838673,4 LBP ( 47,838,673.00 LBP )
Cost/Month: 956773468 LBP ( 956,773,468.00 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Cost/Day: 47838673,4 LBP ( 47,838,673.00 LBP )
Cost/Month: 956773468 LBP ( 956,773,468.00 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Cost/Day: 47838673,4 LBP ( 47,838,673.00 LBP )
Cost/Month: 956773468 LBP ( 956,773,468.00 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Cost/Day: 47838673,4 LBP ( 47,838,673.00 LBP )
Cost/Month: 956773468 LBP ( 956,773,468.00 LBP )
Severe combined immunodeficiency :
Cost/Unit: 1708524,05 LBP ( 1,708,524.00 LBP )
Cost/Day: 47838673,4 LBP ( 47,838,673.00 LBP )
Cost/Month: 956773468 LBP ( 956,773,468.00 LBP )
Common variable immunodeficiency :
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Cost/Day: 3173,03 DKK ( 7,808,657.81 LBP )
Cost/Month: 63460,6 DKK ( 156,173,156.20 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Cost/Day: 3173,03 DKK ( 7,808,657.81 LBP )
Cost/Month: 63460,6 DKK ( 156,173,156.20 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Cost/Day: 3173,03 DKK ( 7,808,657.81 LBP )
Cost/Month: 63460,6 DKK ( 156,173,156.20 LBP )
IgG subclass deficiencies :
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Cost/Day: 3173,03 DKK ( 7,808,657.81 LBP )
Cost/Month: 63460,6 DKK ( 156,173,156.20 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Cost/Day: 3173,03 DKK ( 7,808,657.81 LBP )
Cost/Month: 63460,6 DKK ( 156,173,156.20 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Cost/Day: 3173,03 DKK ( 7,808,657.81 LBP )
Cost/Month: 63460,6 DKK ( 156,173,156.20 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Cost/Day: 3173,03 DKK ( 7,808,657.81 LBP )
Cost/Month: 63460,6 DKK ( 156,173,156.20 LBP )
Severe combined immunodeficiency :
Cost/Unit: 113,3225 DKK ( 278,089.61 LBP )
Cost/Day: 3173,03 DKK ( 7,808,657.81 LBP )
Cost/Month: 63460,6 DKK ( 156,173,156.20 LBP )
Common variable immunodeficiency :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
IgG subclass deficiencies :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Severe combined immunodeficiency :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Common variable immunodeficiency :
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Cost/Day: 412,93 EUR ( 7,572,580.60 LBP )
Cost/Month: 8258,6 EUR ( 151,782,452.90 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Cost/Day: 412,93 EUR ( 7,572,580.60 LBP )
Cost/Month: 8258,6 EUR ( 151,782,452.90 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Cost/Day: 412,93 EUR ( 7,572,580.60 LBP )
Cost/Month: 8258,6 EUR ( 151,782,452.90 LBP )
IgG subclass deficiencies :
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Cost/Day: 412,93 EUR ( 7,572,580.60 LBP )
Cost/Month: 8258,6 EUR ( 151,782,452.90 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Cost/Day: 412,93 EUR ( 7,572,580.60 LBP )
Cost/Month: 8258,6 EUR ( 151,782,452.90 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Cost/Day: 412,93 EUR ( 7,572,580.60 LBP )
Cost/Month: 8258,6 EUR ( 151,782,452.90 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Cost/Day: 412,93 EUR ( 7,572,580.60 LBP )
Cost/Month: 8258,6 EUR ( 151,782,452.90 LBP )
Severe combined immunodeficiency :
Cost/Unit: 14,7474 EUR ( 257,320.70 LBP )
Cost/Day: 412,93 EUR ( 7,572,580.60 LBP )
Cost/Month: 8258,6 EUR ( 151,782,452.90 LBP )
Common variable immunodeficiency :
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Cost/Day: 349,48 EUR ( 6,414,637.45 LBP )
Cost/Month: 6989,6 EUR ( 128,458,169.45 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Cost/Day: 349,48 EUR ( 6,414,637.45 LBP )
Cost/Month: 6989,6 EUR ( 128,458,169.45 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Cost/Day: 349,48 EUR ( 6,414,637.45 LBP )
Cost/Month: 6989,6 EUR ( 128,458,169.45 LBP )
IgG subclass deficiencies :
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Cost/Day: 349,48 EUR ( 6,414,637.45 LBP )
Cost/Month: 6989,6 EUR ( 128,458,169.45 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Cost/Day: 349,48 EUR ( 6,414,637.45 LBP )
Cost/Month: 6989,6 EUR ( 128,458,169.45 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Cost/Day: 349,48 EUR ( 6,414,637.45 LBP )
Cost/Month: 6989,6 EUR ( 128,458,169.45 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Cost/Day: 349,48 EUR ( 6,414,637.45 LBP )
Cost/Month: 6989,6 EUR ( 128,458,169.45 LBP )
Severe combined immunodeficiency :
Cost/Unit: 12,4815 EUR ( 220,560.60 LBP )
Cost/Day: 349,48 EUR ( 6,414,637.45 LBP )
Cost/Month: 6989,6 EUR ( 128,458,169.45 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info